1. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252. https://doi.org/10.1038/32588
2. Mellman I (2013) Dendritic cells: master regulators of the immune response. Cancer Immunol Res 1:145–149. https://doi.org/10.1158/2326-6066.CIR-13-0102
3. Kim MK, Kim J (2019) Properties of immature and mature dendritic cells: phenotype, morphology, phagocytosis, and migration. RSC Adv 9:11230–11238. https://doi.org/10.1039/C9RA00818G
4. Rossi M, Young JW (2005) Human Dendritic Cells: Potent Antigen-Presenting Cells at the Crossroads of Innate and Adaptive Immunity. J Immunol 175:1373–1381. https://doi.org/10.4049/jimmunol.175.3.1373
5. Tisch R (2010) Immunogenic versus tolerogenic dendritic cells: A matter of maturation. Int Rev Immunol 29:111–118. https://doi.org/10.3109/08830181003602515
6. Domogalla MP, Rostan P V., Raker VK, Steinbrink K (2017) Tolerance through education: How tolerogenic dendritic cells shape immunity. Front Immunol 8:1–14. https://doi.org/10.3389/fimmu.2017.01764
7. Manzo E, Cutignano A, Pagano D, et al (2017) A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant response. Sci Rep 7:6286. https://doi.org/10.1038/s41598-017-05969-8
8. Manzo E, Gallo C, Fioretto L, et al (2019) Diasteroselective Colloidal Self-Assembly Affects the Immunological Response of the Molecular Adjuvant Sulfavant. ACS Omega 4:7807–7814. https://doi.org/10.1021/acsomega.8b03304
9. Khameneh HJ, Ho AWS, Spreafico R, et al (2017) The Syk–NFAT–IL-2 Pathway in Dendritic Cells Is Required for Optimal Sterile Immunity Elicited by Alum Adjuvants. J Immunol 198:196–204. https://doi.org/10.4049/jimmunol.1600420
10. Mócsai A, Ruland J, Tybulewicz VLJ (2010) The SYK tyrosine kinase: A crucial player in diverse biological functions. Nat Rev Immunol 10:387–402. https://doi.org/10.1038/nri2765
11. Deczkowska A, Weiner A, Amit I (2020) The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway. Cell 181:1207–1217. https://doi.org/10.1016/j.cell.2020.05.003
12. Ulland TK, Colonna M (2018) TREM2 — a key player in microglial biology and Alzheimer disease. Nat Rev Neurol 14:667–675. https://doi.org/10.1038/s41582-018-0072-1
13. Colonna M, Wang Y (2016) TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci 17:201–207. https://doi.org/10.1038/nrn.2016.7
14. Humphrey MB, Xing J, Titus A (2015) The TREM2-DAP12 signaling pathway in Nasu-Hakola disease: a molecular genetics perspective. Res Reports Biochem 5:89. https://doi.org/10.2147/RRBC.S58057
15. Quan DN, Cooper MD, Potter JL, et al (2008) TREM-2 binds to lipooligosaccharides of Neisseria gonorrhoeae and is expressed on reproductive tract epithelial cells. Mucosal Immunol 1:229–238. https://doi.org/10.1038/mi.2008.1
16. Daws MR, Sullam PM, Niemi EC, et al (2003) Pattern Recognition by TREM-2: Binding of Anionic Ligands. J Immunol 171:594–599. https://doi.org/10.4049/jimmunol.171.2.594
17. Wang Y, Cella M, Mallinson K, et al (2015) TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model. Cell 160:1061–1071. https://doi.org/10.1016/j.cell.2015.01.049
18. Shirotani K, Hori Y, Yoshizaki R, et al (2019) Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cells. Sci Rep 9:1–9. https://doi.org/10.1038/s41598-019-43535-6
19. Iizasa E, Chuma Y, Uematsu T, et al (2021) TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation. Nat Commun 12:2299. https://doi.org/10.1038/s41467-021-22620-3
20. Song W, Hooli B, Mullin K, et al (2017) Alzheimer’s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation. Alzheimer’s Dement 13:381–387. https://doi.org/10.1016/j.jalz.2016.07.004
21. Yao H, Coppola K, Schweig JE, et al (2019) Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities. Front Cell Neurosci 13:457. https://doi.org/10.3389/fncel.2019.00457
22. Ji KY, Kim SM, Yee SM, et al (2021) Cyclophilin A is an endogenous ligand for the triggering receptor expressed on myeloid cells-2 (TREM2). FASEB J 35:1–12. https://doi.org/10.1096/fj.202002325RR
23. Brown GD, Willment JA, Whitehead L (2018) C-type lectins in immunity and homeostasis. Nat Rev Immunol 18:374–389. https://doi.org/10.1038/s41577-018-0004-8
24. Kalia N, Singh J, Kaur M (2021) The role of dectin-1 in health and disease. Immunobiology 226:152071. https://doi.org/10.1016/j.imbio.2021.152071
25. Bouchon A, Hernández-Munain C, Cella M, Colonna M (2001) A Dap12-Mediated Pathway Regulates Expression of Cc Chemokine Receptor 7 and Maturation of Human Dendritic Cells. J Exp Med 194:1111–1122. https://doi.org/10.1084/jem.194.8.1111
26. Tsang E, Giannetti AM, Shaw D, et al (2008) Molecular Mechanism of the Syk Activation Switch. J Biol Chem 283:32650–32659. https://doi.org/10.1074/jbc.M806340200
27. Chae C-S, Kim G-C, Park ES, et al (2017) NFAT1 Regulates Systemic Autoimmunity through the Modulation of a Dendritic Cell Property. J Immunol 199:3051–3062. https://doi.org/10.4049/jimmunol.1700882
28. Barboza BA, Fonseca BPF, Viola JPB (2014) NFAT1 transcription factor in dendritic cells is required to modulate T helper cell differentiation. Immunobiology 219:704–712. https://doi.org/10.1016/j.imbio.2014.05.001
29. Murakami M, Kamimura D, Hirano T (2019) Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines. Immunity 50:812–831. https://doi.org/10.1016/j.immuni.2019.03.027
30. Liu W, Taso O, Wang R, et al (2020) Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions. Hum Mol Genet 29:3224–3248. https://doi.org/10.1093/hmg/ddaa209
31. Ip WKE, Hoshi N, Shouval DS, et al (2017) Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science (80- ) 356:513–519. https://doi.org/10.1126/science.aal3535
32. Ma X, Yan W, Zheng H, et al (2015) Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells. F1000Research 4:1–13. https://doi.org/10.12688/f1000research.7010.1
33. Couper KN, Blount DG, Riley EM (2008) IL-10: The Master Regulator of Immunity to Infection. J Immunol 180:5771–5777. https://doi.org/10.4049/jimmunol.180.9.5771
34. Eisenbarth SC (2019) Dendritic cell subsets in T cell programming: location dictates function. Nat Rev Immunol 19:89–103. https://doi.org/10.1038/s41577-018-0088-1
35. Tacken PJ, De Vries IJM, Torensma R, Figdor CG (2007) Dendritic-cell immunotherapy: From ex vivo loading to in vivo targeting. Nat Rev Immunol 7:790–802. https://doi.org/10.1038/nri2173
36. Ross SH, Cantrell DA (2018) Signaling and Function of Interleukin-2 in T Lymphocytes. Annu Rev Immunol 36:411–433. https://doi.org/10.1146/annurev-immunol-042617-053352
37. Gadani, Sachin P; Cronk J (2013) Interleukin-4: A Cytokine to Remember. J Immunol 189:4213–4219. https://doi.org/10.4049/jimmunol.1202246.Interleukin-4
38. Wunderlich P, Glebov K, Kemmerling N, et al (2013) Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage. J Biol Chem 288:33027–33036. https://doi.org/10.1074/jbc.M113.517540
39. Kober DL, Alexander-Brett JM, Karch CM, et al (2016) Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms. Elife 5:1–24. https://doi.org/10.7554/eLife.20391
40. Sudom A, Talreja S, Danao J, et al (2018) Molecular basis for the loss-of-function effects of the Alzheimer’s disease–associated R47H variant of the immune receptor TREM2. J Biol Chem 293:12634–12646. https://doi.org/10.1074/jbc.ra118.002352
41. Guerreiro R, Wojtas A, Bras J, et al (2013) TREM2 Variants in Alzheimer’s Disease. N Engl J Med 368:117–127. https://doi.org/10.1056/NEJMoa1211851
42. Kong J, Du Z, Dong L (2020) Pinitol Prevents Lipopolysaccharide (LPS)-Induced Inflammatory Responses in BV2 Microglia Mediated by TREM2. Neurotox Res 38:96–104. https://doi.org/10.1007/s12640-020-00187-z
43. Zanoni I, Granucci F (2012) Regulation and dysregulation of innate immunity by NFAT signaling downstream of pattern recognition receptors (PRRs). Eur J Immunol 42:1924–1931. https://doi.org/10.1002/eji.201242580
44. Zanoni I, Ostuni R, Capuano G, et al (2009) CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 460:264–268. https://doi.org/10.1038/nature08118
45. Mourão-Sá D, Robinson MJ, Zelenay S, et al (2011) CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses. Eur J Immunol 41:3040–3053. https://doi.org/10.1002/eji.201141641
46. Švajger U, Rožman PJ (2020) Recent discoveries in dendritic cell tolerance-inducing pharmacological molecules. Int Immunopharmacol 81:106275. https://doi.org/10.1016/j.intimp.2020.106275
47. Theofilopoulos AN, Kono DH, Baccala R (2017) The multiple pathways to autoimmunity. Nat Immunol 18:716–724. https://doi.org/10.1038/ni.3731
48. Macciò A, Madeddu C (2020) Blocking inflammation to improve immunotherapy of advanced cancer. Immunology 159:357–364. https://doi.org/10.1111/imm.13164
49. Wculek SK, Cueto FJ, Mujal AM, et al (2020) Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol 20:7–24. https://doi.org/10.1038/s41577-019-0210-z